SLI
1.902,17
PKT
-13,18
PKT
-0,69
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.11.24 | Richemont Buy | UBS AG | |
| 08.11.24 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.11.24 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 07.11.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 07.11.24 | Swiss Re Sector Perform | RBC Capital Markets | |
| 07.11.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 07.11.24 | Zurich Insurance Neutral | UBS AG | |
| 07.11.24 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 07.11.24 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 04.11.24 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 31.10.24 | UBS Hold | Deutsche Bank AG | |
| 31.10.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 31.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 31.10.24 | UBS Outperform | RBC Capital Markets | |
| 31.10.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 30.10.24 | Roche Neutral | UBS AG | |
| 30.10.24 | Novartis Outperform | Bernstein Research | |
| 30.10.24 | Novartis Hold | Deutsche Bank AG | |
| 30.10.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 30.10.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 30.10.24 | UBS Outperform | RBC Capital Markets | |
| 30.10.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 30.10.24 | Richemont Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.10.24 | Novartis Buy | UBS AG | |
| 29.10.24 | Nestlé Market-Perform | Bernstein Research | |
| 29.10.24 | Novartis Outperform | Bernstein Research | |
| 29.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 29.10.24 | Novartis Buy | UBS AG | |
| 29.10.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 29.10.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 29.10.24 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 25.10.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 24.10.24 | Roche Kaufen | DZ BANK | |
| 24.10.24 | Roche Sell | Deutsche Bank AG | |
| 23.10.24 | Roche Neutral | UBS AG | |
| 23.10.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 23.10.24 | Roche Hold | Jefferies & Company Inc. | |
| 23.10.24 | Givaudan Neutral | UBS AG | |
| 22.10.24 | Nestlé Kaufen | DZ BANK | |
| 18.10.24 | Swiss Re Sell | UBS AG |